Fulton Breakefield Broenniman’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Fulton Breakefield Broenniman's LLY Position: Q3 2026 in Review
Fulton Breakefield Broenniman reduced its Eli Lilly (LLY) stake by 1.2% in Q3 2026, selling an estimated $441K and leaving 29,651 shares worth $34.3M. The position accounts for 1.99% of the portfolio, ranked #12.
Fulton Breakefield Broenniman first reported a position in LLY in Q3 2019 and has held it in 29 quarters since. The position peaked at $39.5M in Q2 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Fulton Breakefield Broenniman held 29,651 shares of Eli Lilly worth $34.3M as of Q3 2026.
- Fulton Breakefield Broenniman sold 374 Eli Lilly shares in Q3 2026, an estimated $441K.
- Eli Lilly made up 1.99% of Fulton Breakefield Broenniman's portfolio in Q3 2026, its #12 holding.
- Fulton Breakefield Broenniman first reported a position in Eli Lilly in Q3 2019 and has held it in 29 quarters since.
- Fulton Breakefield Broenniman's Eli Lilly position peaked at $39.5M in Q2 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Fulton Breakefield Broenniman's 13F filing for Q3 2026, filed 3 Nov 2026.